Buscar | UBUNTU-SAFARI

Marketanalysis agregó una foto Other
2025-04-18 10:13:29 - Translate -

Orphan Drugs Market Size Share, Growth & Demands
IMARC Group, a leading market research company, has recently released a report titled “Orphan Drugs Market Report by Drug Type (Biological, Non-Biological), Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Others), Phase (Phase I, Phase II, Phase III, Phase IV), Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Ishiikasharma123

agregó una foto Health
2024-04-22 08:17:48 - Translate -

Breaking Barriers Access and Affordability in the Orphan Drugs Market
Orphan drugs market size was valued at USD 160.78 billion in 2021 and is projected to grow from USD 175.57 Billion in 2022 to USD 355.00 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2022 - 2030). In the vast landscape of pharmaceuticals, there exists a niche yet crucial sector known as orphan drugs. These medications are...

0 Commentarios 0 Acciones 4K Views 0 Vista previa

Please log in to like, share and comment!

Patrocinados

google-site-verification: google037b30823fc02426.html

Patrocinados

google-site-verification: google037b30823fc02426.html